Article
Generation of two induced pluripotent stem cell lines from blood cells of a prostate cancer patient carrying germline mutation in CHEK2.
Stem cell research - 1 May 2021
Liu Ran, Qian Kaiyu, Xiao Yu, Jiang Wei
Abstract excerpt
Germline mutations of CHEK2 have been reported in various types of disease including breast cancer, ovarian cancer, colorectal cancer and prostate cancer. We generated two iPSC lines ZNHi001-A and ZNHi001-B from a prostate cancer patient carrying germline mutation in CHEK2 (c.667C>T, also p.R223C) which may increase the risk of prostate cancer. Pluripotency and multi-lineage differentiation capacity of the two...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
